We have previously described cells with a similar phenotype (e.g., CD14+, CD163+, and CD209+) as infiltrating post-imatinib-treated fibrosarcomatous dermatofibrosarcoma protuberans, and these same myeloid components have been also found in human renal carcinomas [27, 32]. This evidence concerns the gene CD163 and renal carcinoma.